Advertisement

Ads Placeholder
Loading...

Hygrovest Limited

HGV.AXASX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.05
$0.00(0.00%)
Australian Market opens in 61h 52m

Hygrovest Limited Fundamental Analysis

Hygrovest Limited (HGV.AX) shows moderate financial fundamentals with a PE ratio of -77.06, profit margin of -50.38%, and ROE of -0.68%. The company generates $0.0B in annual revenue with strong year-over-year growth of 29.89%.

Key Strengths

Cash Position215.28%
PEG Ratio-0.77
Current Ratio135.53

Areas of Concern

ROE-0.68%
Operating Margin-4.24%
We analyze HGV.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 11.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
11.5/100

We analyze HGV.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

HGV.AX struggles to generate sufficient returns from assets.

ROA > 10%
-0.60%

Valuation Score

Excellent

HGV.AX trades at attractive valuation levels.

PE < 25
-77.06
PEG Ratio < 2
-0.77

Growth Score

Excellent

HGV.AX delivers strong and consistent growth momentum.

Revenue Growth > 5%
29.89%
EPS Growth > 10%
96.55%

Financial Health Score

Excellent

HGV.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
135.53

Profitability Score

Weak

HGV.AX struggles to sustain strong margins.

ROE > 15%
-67.88%
Net Margin ≥ 15%
-50.38%
Positive Free Cash Flow
No

Key Financial Metrics

Is HGV.AX Expensive or Cheap?

P/E Ratio

HGV.AX trades at -77.06 times earnings. This suggests potential undervaluation.

-77.06

PEG Ratio

When adjusting for growth, HGV.AX's PEG of -0.77 indicates potential undervaluation.

-0.77

Price to Book

The market values Hygrovest Limited at 0.53 times its book value. This may indicate undervaluation.

0.53

EV/EBITDA

Enterprise value stands at -12.18 times EBITDA. This is generally considered low.

-12.18

How Well Does HGV.AX Make Money?

Net Profit Margin

For every $100 in sales, Hygrovest Limited keeps $-50.38 as profit after all expenses.

-50.38%

Operating Margin

Core operations generate -4.24 in profit for every $100 in revenue, before interest and taxes.

-4.24%

ROE

Management delivers $-0.68 in profit for every $100 of shareholder equity.

-0.68%

ROA

Hygrovest Limited generates $-0.60 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.60%

Following the Money - Real Cash Generation

Operating Cash Flow

Hygrovest Limited generates limited operating cash flow of $-3.49M, signaling weaker underlying cash strength.

$-3.49M

Free Cash Flow

Hygrovest Limited generates weak or negative free cash flow of $-3.49M, restricting financial flexibility.

$-3.49M

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

HGV.AX converts -34.56% of its market value into free cash.

-34.56%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-77.06

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.77

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.53

vs 25 benchmark

P/S Ratio

Price to sales ratio

38.83

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

135.53

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.01

vs 25 benchmark

ROA

Return on assets percentage

-0.01

vs 25 benchmark

ROCE

Return on capital employed

-0.05

vs 25 benchmark

How HGV.AX Stacks Against Its Sector Peers

MetricHGV.AX ValueSector AveragePerformance
P/E Ratio-77.0628.54 Better (Cheaper)
ROE-0.68%738.00% Weak
Net Margin-50.38%-43982.00% (disorted) Weak
Debt/Equity0.000.34 Strong (Low Leverage)
Current Ratio135.532806.01 Strong Liquidity
ROA-0.60%-14624.00% (disorted) Weak

HGV.AX outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Hygrovest Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-99.14%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-100.66%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-115.72%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ